Class IA molecules play a major role in the presentation of peptide epitopes from intracellular parasites to CD8 T cells. Class IB molecules are not as polymorphic as class IA and their function is less well understood. We plan to utilize H-2b mice that have their class IA (KbDb) genes deleted. Unlike previously described class I deficient animals (beta-2M-/- and Tap-1-/ -) these mice have a complete absence of class IA molecules but retain class IB expression. They will be tested for their ability to respond to 3 intracellular pathogens, Listeria monocytogenes (LM), vaccinia virus, and vesicular stomatitis virus. CD8 cells are known to play a role in resistance to these pathogens and in the case of LM, it is known that CTL can be generated in vitro against this pathogen presented by 2 class IB molecules, M3 and Qa-1/b. The role that class IB molecular play in these infections in providing immunity will be analyzed by assessing the role of various T cell subsets as well as NK cells in vivo. We will also analyze these responses in vitro and identify the epitopes presented by class IB molecules to antigen specific CD8 cells. Finally, since Kb -/-Db-/-mice cannot generate their CD8 repertoire on class IA molecules, we will determine whether these animals have a repertoire directed against both self H-2b class IA molecules as well as other class IA alloantigens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI045764-04
Application #
6534171
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Kirkham, Perry M
Project Start
1999-09-01
Project End
2004-06-30
Budget Start
2002-09-01
Budget End
2003-06-30
Support Year
4
Fiscal Year
2002
Total Cost
$249,227
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Mandraju, Rajakumar; Murray, Sean; Forman, James et al. (2014) Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo. J Immunol 192:4303-15
Chowdhury, Fatema Z; Estrada, Leonardo D; Murray, Sean et al. (2014) Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions. PLoS One 9:e92187
Chowdhury, Fatema Z; Ramos, Hilario J; Davis, Laurie S et al. (2011) IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo. Blood 118:3890-900
Sieve, Amy N; Meeks, Karen D; Lee, Suheung et al. (2010) A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-ýý production. Eur J Immunol 40:2236-47
Toneff, Michael J; Du, Zhijun; Dong, Jie et al. (2010) Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis. Neoplasia 12:718-26
Ramos, Hilario J; Davis, Ann M; Cole, Alexander G et al. (2009) Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates. Blood 113:5516-25
Sinai, Parisa; Berg, Rance E; Haynie, J Marshall et al. (2007) Imatinib mesylate inhibits antigen-specific memory CD8 T cell responses in vivo. J Immunol 178:2028-37
Berg, Rance E; Forman, James (2006) The role of CD8 T cells in innate immunity and in antigen non-specific protection. Curr Opin Immunol 18:338-43
Berg, Rance E; Crossley, Emily; Murray, Sean et al. (2005) Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. J Immunol 175:1751-7
Gunturi, Anasuya; Berg, Rance E; Crossley, Emily et al. (2005) The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells. Eur J Immunol 35:766-75

Showing the most recent 10 out of 15 publications